Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of rasagiline (TVP-1012) in Japanese PD patients
NCT02337764Phase 3Completed
- Sponsor
- Takeda
- Start
- Feb 2015
- Primary completion
- Sep 2016
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 3 trial of rasagiline in Parkinson's disease (PD), sponsored by Takeda. Started Feb 2015; status: completed.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02337764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02337764.